This strategic move brings stability to Embecta, addressing challenges faced since its spin-off from Becton Dickinson & Co.

MGS says Auto-injector Reimagined drug-delivery device, which harnesses its design and moldmaking capabilities, can help ...

Diabetes hardware company embecta aims to look beyond insulin and reshape itself into a more varied drug delivery provider—and it’s kick-starting that effort with the acquisition of a glo | Embecta ...

Embecta (Nasdaq:EMBC) announced today that it entered into a definitive agreement to acquire Owen Mumford Holdings Limited.

Aiming to deliver blockbuster sales of its Alzheimer’s-disease-fighting antibody Leqembi in its 2027 fiscal year, Eisai has cleared a key regulatory hurdle in its quest to grow the medicine's reach.